patent/BR-112018006039-A2

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112018006039-A2

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_988a6f37a695a0b266041aa15a184fd9
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-592 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-593 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4875 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4825 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-593 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-592 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44
filingDate	2016-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_babb6519bbc05b8806aabfd46343cf64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fb161ac2b2b5ed7474c38346dd8d712 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bac73afe74551f6c9b2bcf669ffb6e79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8732c6abaa4b7d380eb4326aa82b6266 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4be40d0a4eaca69c5b76f56f26cac147 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a615e48dab7e04607d80dcea5d8f3bbb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50249e13b1b2615dc582a8488874f8dd
publicationDate	2018-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	BR-112018006039-A2
titleOfInvention	adjuvant therapy with 25-hydroxyvitamin d and articles therefor
abstract	Methods, compositions and kits for adjuvant therapy using 25-hydroxyvitamin d are disclosed. 25-hydroxyvitamin d may be administered together with an agent that increases the risk of hypocalcemia, such as cinacalcete or a pharmaceutically acceptable salt thereof, and / or an anticancer agent. adjuvant therapy is effective for treating and preventing iatrogenic hypocalcemia and / or secondary hyperparathyroidism, as well as delaying cancer progression and time to a skeletal event (er) after treatment.
priorityDate	2014-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283731 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519522

Total number of triples: 60.